Head-to-head for women
HumeCare+ vs Lttl
HumeCare+ and Lttl both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
HumeCare+
Ranked #50 for women · Grade C
Luna Fit
Best for: Women who care more about how much of the loss is muscle than about the headline rate, and who will accept an assessment before seeing a number.
Visit HumeCare+Lttl
Higher scoreRanked #21 for women · Grade B−
Luna Fit
Best for: Readers treating insulin resistance who want the month-to-month rate rather than a prepay rung, and who will open the plan selector: the real ladder is public, complete and honest, and it is one click from a headline figure that is not.
Visit LttlThe verdict for women
Lttl edges out HumeCare+ on the Luna Fit Score, 81 to 73 (B− vs C). Readers treating insulin resistance who want the month-to-month rate rather than a prepay rung, and who will open the plan selector: the real ladder is public, complete and honest, and it is one click from a headline figure that is not. The reasoning behind that number is in our Lttl write-up for women.
HumeCare+ is still a genuine option — the only desk here that titrates against lean mass rather than scale weight — a weekly body scan is included — and the only one that will not tell you a price before you finish its assessment. Weigh the six women's-health factors below against your own priorities; the HumeCare+ scorecard goes through each of them, and if neither of these two is the one, the full field we rank against HumeCare+ widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | HumeCare+ | Lttl |
|---|---|---|
| Luna Fit Score | 73/100 · C | 81/100 · B− |
| Overall rank | #50 | #21 |
| Semaglutide | $199/mo month-to-month at checkout, injection or oral — the marketing site publishes no price at all | $199/mo month-to-month (from $129/mo on a 12-month plan billed $1,548 up front) — the product card advertises the $129 rung |
| Tirzepatide | $299/mo month-to-month with B12 and glycine — priced past the intake, absent from the marketing site | $279/mo month-to-month (from $199/mo on a 12-month plan billed $2,388 up front) — the product card advertises $129, which no tirzepatide tier costs |
| Coverage | Not disclosed | All 50 states plus Washington D.C., with a stated caveat that some services may not be |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Luna Fit
HumeCare+
Ranked #50 · Grade C
What we like
- Titrates against fat and lean mass measured weekly at home rather than against the scale — the one thing this category almost never does
- Includes a body-composition device with the program at no separate charge
- Builds glycine, B12 and B6 into the protocol for muscle preservation and side effects, rather than selling them as an upsell
The caveats
- ⚠ Publishes no price anywhere on its marketing site — the figures above are reachable only by completing the assessment
- ⚠ "From $199" is the semaglutide rung, not the program: tirzepatide is $299, and it is sold without appearing on the marketing site at all
- ⚠ $199 is a floor rather than a rate — a non-refundable fee is charged at enrollment and again at every refill, and the site does not print it
Luna Fit
Lttl
Ranked #21 · Grade B−
What we like
- Publishes its entire price ladder — every product, every term, every rung — in the public page source, each one labeled with what it bills (“$199/mo every month” beside “$1,548 annually”), with no intake quiz standing between you and the number
- A genuine month-to-month rung exists and is purchasable for every product, with no contracts and no minimum term, so the prepay ladder is an optional discount rather than the only way in
- Both molecules across three routes — injection, orally disintegrating tablet, and lower-dose microdose lines sold as their own products with their own published ladders rather than quoted at the full-dose price
The caveats
- All fourteen product cards hardcode “from $129/mo”. For semaglutide that is the twelve-month rung billed $1,548 up front; for tirzepatide, the semaglutide ODT and the microdose ODT it is a price purchasable at no tier at all
- The month-to-month rates are roughly 40% above the advertised figure — $199 for semaglutide and $279 for tirzepatide against the $129 on every card
- Names no medical director and no prescribing clinician, offers and requires no labs or bloodwork, and carries no third-party certification such as LegitScript
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither HumeCare+ nor Lttl is only worth comparing with the other. HumeCare+ is also written up against CoreAge Rx, 20 points apart on the Luna Fit Score — see the HumeCare+–CoreAge Rx head-to-head. Lttl is also written up against CoreAge Rx, 12 points apart — see Lttl against CoreAge Rx, factor by factor.
- HumeCare+ vs CoreAge Rx
- HumeCare+ vs Enhance MD
- HumeCare+ vs yourEra
- Lttl vs Sesame Care
- Lttl vs HealthRX
- Lttl vs MadeMed
Or browse the full comparison hub.